{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:37:34Z","timestamp":1794278254716,"version":"4.9.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>HAE with normal C1 inhibitor (HAE-nC1-INH) has been identified as a bradykinin mediated angioedema. Estrogens are one of the main trigger factors. Pregnancy in HAE with C1 inhibitor deficiency showed variable course, however, few reports are available for HAE-nC1-INH. We evaluated the course of pregnancies in women diagnosed with HAE-nC1-INH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Women with diagnosis of HAE-nC1-INH according to the following criteria: clinical manifestations similar to HAE-C1-INH, normal biochemical evaluation and family history were included. A questionnaire about pregnancies was applied after consent. Genetic evaluation for known mutations was performed in all patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 45 pregnancies occurring in 26 HAE-nC1-INH patients were evaluated (7\/26 patients with <jats:italic>F12<\/jats:italic> variant). Spontaneous abortion was reported in 8\/45 (17.8%) pregnancies. Onset of attacks started before the pregnancy in 18\/26 patients; during the pregnancy in 2\/26; and after the pregnancy in 6\/26. HAE attacks occurred in 24\/37 pregnancies (64,7%): during the 1st trimester in 41.7%; 2nd trimester in 12.5%; 3rd trimester in 20.8%; 1st and 3rd trimesters in 4.2% and during the whole pregnancy in 20.8%. Among 15\/18 patients who had attacks before pregnancy, symptoms persisted with worsening in 9\/15; improvement in 4\/15; no change in 1\/15, and no response in 1\/15.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The occurrence of abortion in HAE-nC1-INH was similar to the expected for not affected women. The 1st trimester of the pregnancy was more symptomatic for HAE-nC1-INH women. Considering the strong relevance of estrogens in HAE-nC1-INH, pregnancy could worsen the course of disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/falgy.2022.846968","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T04:46:17Z","timestamp":1645073177000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor"],"prefix":"10.3389","volume":"3","author":[{"given":"Natalia","family":"Gabriel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Marcelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana P. L.","family":"Ferriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Karla","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis A.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozana F.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herberto","family":"Chong-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Rosario Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange O. R.","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao B.","family":"Pesquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anete S.","family":"Grumach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.jaci.2021.05.016","article-title":"Consensus on treatment goals in hereditary angioedema: a global Delphi initiative","volume":"148","author":"Maurer","year":"2021","journal-title":"J Allergy Clin Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12016-016-8561-8","article-title":"HAE pathophysiology and underlying mechanisms","volume":"51","author":"Zuraw","year":"2016","journal-title":"Clin Rev Allergy Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1 inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1016\/j.jaip.2021.03.008","article-title":"The expanding spectrum of mutations in hereditary angioedema","volume":"9","author":"Veronez","year":"2021","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/cei.12820","article-title":"Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema","volume":"185","author":"Deroux","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13023-020-01570-x","article-title":"Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence","volume":"15","author":"Bork","year":"2020","journal-title":"Orphanet J Rare Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ajog.2010.03.003","article-title":"Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate","volume":"203","author":"Martinez-Saguer","year":"2010","journal-title":"Am J Obstet Gynecol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejogrb.2010.05.008","article-title":"The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey","volume":"152","author":"Czaller","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.18176\/jiaci.0175","article-title":"Pregnancy and postpartum in hereditary angioedema with C1 inhibitor deficit in women who have no access to therapy","volume":"27","author":"Machado","year":"2017","journal-title":"J Investig Allergol Clin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1398-9995.2007.01579.x","article-title":"Oestrogen-dependent hereditary angio-oedema with normal C1 inhibitor: description of six new cases and review of pathogenic mechanisms and treatment","volume":"63","author":"Serrano","year":"2008","journal-title":"Allergy."},{"key":"B11","doi-asserted-by":"publisher","first-page":"957507","DOI":"10.1155\/2010\/957507","article-title":"Obstetrical complications and outcome in two families with hereditary angioedema due to mutation in the F12 gene","volume":"2010","author":"Picone","year":"2010","journal-title":"Obstet Gynecol Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.anai.2012.05.022","article-title":"Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families","volume":"109","author":"Marcos","year":"2012","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ijoa.2014.05.010","article-title":"Caesarean delivery in a parturient with type III hereditary angioedema","volume":"23","author":"Soltanifar","year":"2014","journal-title":"Int J Obstet Anesth."},{"key":"B14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000376547","article-title":"Coagulation factor XII gene mutation in Brazilian families with hereditary angioedema with normal C1 inhibitor","volume":"166","author":"Moreno","year":"2015","journal-title":"Int Arch Allergy Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijoa.2018.07.003","article-title":"Repeated attacks of type III hereditary angioedema with factor XII mutation during pregnancy","volume":"36","author":"Feray","year":"2018","journal-title":"Int J Obstet Anesth."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.jaip.2017.12.022","article-title":"Use of pdC1-INH concentrate for long-term prophylaxis during pregnancy in hereditary angioedema with normal C1-INH","volume":"6","author":"Garcia","year":"2018","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jaip.2018.10.056","article-title":"C1-INH concentrate for prophylaxis during pregnancy in hereditary angioedema with normal C1-INH","volume":"7","author":"Valencia","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e14541","DOI":"10.1111\/dth.14541","article-title":"Hereditary angioedema type III, recurrent pregnancy loss and heterozygous MTHFR mutation","volume":"33","author":"Napolitano","year":"2020","journal-title":"Dermatol Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1055\/s-0040-1718955","article-title":"Short-term Prophylaxis for delivery in pregnant women with hereditary angioedema with normal C1-Inhibitor","volume":"42","author":"Moraes","year":"2020","journal-title":"Rev Bras Ginecol Obstet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaip.2017.09.025","article-title":"Hereditary angioedema with normal C1 inhibitor and F12 mutations in 42 brazilian families","volume":"6","author":"Veronez","year":"2018","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.2500\/aap.2012.33.3627","article-title":"Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel","volume":"33","author":"Zuraw","year":"2012","journal-title":"Allergy Asthma Proc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/IJWH.S46460","article-title":"Management of hereditary angioedema in pregnant women: a review","volume":"9","author":"Caballero","year":"2014","journal-title":"Intern J Womens Health."},{"key":"B23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jaci.2011.11.025","article-title":"International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency","volume":"129","author":"Caballero","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"106080","DOI":"10.1016\/j.intimp.2019.106080","article-title":"Exogenous hormones and hereditary angioedema","volume":"78","author":"Gompel","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jaci.2009.03.038","article-title":"Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy","volume":"124","author":"Bork","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1710-1492-6-16","article-title":"Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions","volume":"6","author":"Binkley","year":"2010","journal-title":"Allergy Asthma Clin Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ajog.2008.04.034","article-title":"Disease expression in women with hereditary angioedema","volume":"199","author":"Bouillet","year":"2008","journal-title":"Am J Obstet Gynecol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.iac.2013.07.002","article-title":"Hereditary angioedema with normal C1 inhibitor","volume":"33","author":"Bork","year":"2013","journal-title":"Immunol Allergy Clin North Am."},{"key":"B29","first-page":"700","article-title":"Modulatory effect of endopeptidase inhibitors on bradykin-induced contraction of rat uterus","volume":"266","author":"Schriefer","year":"1993","journal-title":"J Pharmacol Exp Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15586\/aei.v49i4.57","article-title":"Management of hereditary angioedema type I and homozygous MTHFR mutation during pregnancy","volume":"49","author":"Batlle","year":"2021","journal-title":"Allergol Immunopathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.6061\/clinics\/2018\/e310","article-title":"Brazilian guidelines for hereditary angioedema management - 2017 update part 1: definition, classification and diagnosis","volume":"73","author":"Giavina-Bianchi","year":"2018","journal-title":"Clinics."}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2022.846968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T04:46:20Z","timestamp":1645073180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2022.846968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":31,"alternative-id":["10.3389\/falgy.2022.846968"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2022.846968","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"article-number":"846968"}}